Mild Traumatic Brain Injury

Neurology·MeSH: Brain Concussion

5 drugs in development·3 companies·7 clinical trials

Drug Pipeline by Phase

Phase 2(1)

Drug	Company
onp-002	ORAGENICS INC (OGEN)

Preclinical(4)

Drug	Company
ALPHA-1062 intranasal (ALPHA-1062IN)	Alpha Cognition Inc. (ACOG)
alpha-1062 sublingual	Alpha Cognition Inc. (ACOG)
kls-13019	NEUROPATHIX, INC. (TYGS)
kls-13023	NEUROPATHIX, INC. (TYGS)

Compare drugs

onp-002 vs ALPHA-1062 intranasal (ALPHA-1062IN)onp-002 vs alpha-1062 sublingual onp-002 vs kls-13019

Frequently asked questions

How many drugs are in development for Mild Traumatic Brain Injury?

BioSniper tracks 5 drugs in development for Mild Traumatic Brain Injury across 3 companies.

How many clinical trials target Mild Traumatic Brain Injury?

There are 7 clinical trials targeting Mild Traumatic Brain Injury tracked by BioSniper.

Deep-dive into Mild Traumatic Brain Injury

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis

Mild Traumatic Brain Injury — Drugs in Development & Clinical Trials | BioSniper